These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2178128)

  • 1. Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group.
    Hersh EM; Funk CY; Petersen EA; Mosier DE
    Dev Biol Stand; 1990; 72():355-63. PubMed ID: 2178128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
    Hersh EM; Funk CY; Ryschon KL; Petersen EA; Mosier DE
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):553-61. PubMed ID: 1657074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.
    Hersh EM; Brewton G; Abrams D; Bartlett J; Galpin J; Gill P; Gorter R; Gottlieb M; Jonikas JJ; Landesman S
    JAMA; 1991 Mar; 265(12):1538-44. PubMed ID: 1671884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized, placebo-controlled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients. The HIV87 Study Group.
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):83-9. PubMed ID: 8094001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS.
    Sunderman FW
    Ann Clin Lab Sci; 1991; 21(1):70-81. PubMed ID: 1849385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDS.
    Stadler I; Chadha KC; Nakeeb S; Toumbis C; Butsch J; Mathur N; Munschauer F; Vladutiu A; Satchidanand SK; Ambrus JL
    J Pharmacol Exp Ther; 1994 Jan; 268(1):10-3. PubMed ID: 8301544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
    Hersh EM; Funk CY; Petersen EA; Ryschon KL; Mosier DE
    Int J Immunopharmacol; 1993 Feb; 15(2):137-43. PubMed ID: 8385652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the murine, retrovirus-induced lymphoproliferative immunodeficiency disease (LP-BM5) in C57BL/10 mice with the immunomodulator Imexon.
    Funk CY; Eisman J; Hersh EM
    AIDS Res Hum Retroviruses; 1992 May; 8(5):633-8. PubMed ID: 1515214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled dose response study of intravenous sodium diethyldithiocarbamate in patients with advanced human immunodeficiency virus infection.
    Kaplan CS; Petersen EA; Yocum D; Hersh EM
    Life Sci; 1989; 45(22):iii-ix. PubMed ID: 2557513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
    Chen C; Zhou J; Xu H; Jiang Y; Zhu G
    Biol Trace Elem Res; 1997; 59(1-3):187-93. PubMed ID: 9522061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection.
    Lang JM; Touraine JL; Trepo C; Choutet P; Kirstetter M; Falkenrodt A; Herviou L; Livrozet JM; Retornaz G; Touraine F
    Lancet; 1988 Sep; 2(8613):702-6. PubMed ID: 2901566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac involvement in HIV infection: a prospective, multicenter clinical and echocardiographic study].
    Mirri A; Rapezzi C; Iacopi F; Ortolani P; Binetti G; Fabbri M; Ortolani P; Zauli T; Pintori C; Baroni M
    Cardiologia; 1990 Mar; 35(3):203-9. PubMed ID: 2245421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical manifestations of acquired immunologic deficiency syndrome (AIDS)].
    Goebel FD
    Acta Med Austriaca; 1987; 14(1):1-4. PubMed ID: 3475926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
    Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.